Outcomes and survival prediction models for severe adult acute respiratory distress syndrome treated with extracorporeal membrane oxygenation. Although the use of ECMO for severe refractory ARDS has markedly increased since 2009, in-hospital mortality remains high (from 35 to 45%). In addition, despite major technological improvement of the devices, ECMO is still associated with numerous therapy-related complications and significant physical/psychological long-term impairment.

Read More